Abstract
Fibromyalgia is an enigmatic medical condition whose specific etiology remains undiscovered but currently plagues five million Americans [1]. Research indicates that the origin of the disease is most likely multifactorial. Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia.
Keywords: Fibromyalgia, Treatment, Pain, Sleep, Serotonin, Antidepressants, SSRIs, HPA, Estrogen
Current Pharmaceutical Design
Title: Combination Therapy in Fibromyalgia
Volume: 12 Issue: 1
Author(s): A. H. Clayton and S. G. West
Affiliation:
Keywords: Fibromyalgia, Treatment, Pain, Sleep, Serotonin, Antidepressants, SSRIs, HPA, Estrogen
Abstract: Fibromyalgia is an enigmatic medical condition whose specific etiology remains undiscovered but currently plagues five million Americans [1]. Research indicates that the origin of the disease is most likely multifactorial. Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia.
Export Options
About this article
Cite this article as:
Clayton H. A. and West G. S., Combination Therapy in Fibromyalgia, Current Pharmaceutical Design 2006; 12 (1) . https://dx.doi.org/10.2174/1381612810606010011
DOI https://dx.doi.org/10.2174/1381612810606010011 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Comprehensive Literature Search: Drugs as Possible Triggers of Takotsubo Cardiomyopathy
Current Clinical Pharmacology Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine The Interplay between the Gut Immune System and Microbiota in Health and Disease: Nutraceutical Intervention for Restoring Intestinal Homeostasis
Current Pharmaceutical Design Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
Current Topics in Medicinal Chemistry Beyond Rodent Models of Pain: Non-Human Primate Models for Evaluating Novel Analgesic Therapeutics and Elaborating Pain Mechanisms
CNS & Neurological Disorders - Drug Targets Hydroxamate Inhibitor Profiling of Both Zn2+- and Ni2+-Activated Glyoxalase I Metalloenzymes Having Diverse Quaternary Structures
Letters in Drug Design & Discovery From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression
Current Neuropharmacology Development of Neurotrophic Molecules for Treatment of Neurode-generation
Current Protein & Peptide Science Painful Peripheral Neuropathies
Current Neuropharmacology Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
Current Vascular Pharmacology Anemia in Patients with Diabetic Foot Ulcer: Effects on Diabetic Microvascular Complications and Related Conditions
Endocrine, Metabolic & Immune Disorders - Drug Targets Surgical Complications of Hyperglycaemia
Current Diabetes Reviews Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis
Current Vascular Pharmacology Anti-Diabetic Effects of Isolated Lipids from Natural Sources through Modulation of Angiogenesis
Current Molecular Pharmacology Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research Conformations and Assembly of Amyloid Oligomers by Electrospray Ionisation - Ion Mobility Spectrometry - Mass Spectrometry
Current Analytical Chemistry Glucose and LDL Lowering: The Need for Intensive Therapy
Current Vascular Pharmacology Efficacy of Pentoxifylline in the Management of Microalbuminuria in Patients with Diabetes
Current Diabetes Reviews PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design